ArticleProceedings. IEEE International Symposium on Biomedical Imaging2020
CHARACTERIZING FREQUENCY-SELECTIVE NETWORK VULNERABILITY FOR ALZHEIMER'S DISEASE BY IDENTIFYING CRITICAL HARMONIC PATTERNS.
Article in Proceedings. IEEE International Symposium on Biomedical Imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Alzheimer's disease (AD) is a multi-factor neurodegenerative disease that selectively affects certain regions of the brain while other areas remain unaffected. The underlying mechanisms of this selectivity, however, are still largely elusive. To address this challenge, we propose a novel longitudinal network analysis method employing sparse logistic regression to identify frequency-specific oscillation patterns which contribute to the selective network vulnerability for patients at risk of advancing to the more severe stage of dementia. We fit and apply our statistical method to more than 100 longitudinal brain networks, and validate it on synthetic data. A set of critical connectome pathways are identified that exhibit strong association to the progression of AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.